Comparison between 18 F-FDG PET/MRI and CT for distant metastases detection in restaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy

Abstract Purpose To evaluate the diagnostic accuracy of total-body 18 F-FDG PET/MRI compared with contrast-enhanced CT in detecting distant metastases in patients with locally advanced rectal cancer (LARC) after neoadjuvant chemoradiotherapy (pCRT). Methods This retrospective study included patients with LARC treated with pCRT between 2016 and 2019. Both contrast-enhanced CT and 18 F-FDG PET/MRI were performed within 6–8 weeks after completion of pCRT. Two independent expert teams assessed the presence of hepatic, pulmonary, lymph node, and other distant metastases. Histopathology and/or radiological follow-up served as the reference standard. Sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), and AUC were compared between the two modalities. Results Metastases were confirmed in 17/51 patients (33.3%). PET/MRI showed significantly higher specificity (100% vs. 86%, p = 0.0313), PPV (100% vs. 45.5%, p = 0.0313), and accuracy (96.1% vs. 82.4%, p = 0.0156) for the detection of liver metastases compared with CT. No significant differences were found for other metastatic sites; however, PET/MRI demonstrated overall better performance for global M staging (84.3% vs. 80.4%) and for detecting metastases outside the liver, lungs, or distant lymph nodes (100% vs. 94.1%). Conversely, CT showed higher accuracy than PET/MRI for the detection of pulmonary metastases (88.2% vs. 84.3%) and distant lymph node metastases (96.1% vs. 90.2%). Conclusions 18 F-FDG PET/MRI performs significantly better than CT in detecting liver metastases and demonstrates higher accuracy for overall M staging and for identifying metastases outside the liver, lungs, or distant lymph nodes after pCRT in patients with LARC. Although CT appears more accurate for detecting lung and distant lymph node metastases, PET/MRI may improve overall restaging accuracy.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Imaging
Published
2026-09-01
DOI
https://doi.org/10.1007/s40336-026-00798-0
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison between 18 F-FDG PET/MRI and CT for distant metastases detection in restaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy

Quoc Riccardo Bao, Emilio Quaia, Amalia Lupi, Filippo Crimì et al.
Clinical and Translational Imaging
Colorectal Cancer Surgical Treatments
article

Comparison between 18 F-FDG PET/MRI and CT for distant metastases detection in restaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy

Quoc Riccardo Bao, Emilio Quaia, Amalia Lupi, Filippo Crimì, Chiara Zanon, Alessandra Pulvirenti, Giulio Cabrelle, Francesca Serani, Diego Cecchin, Gaya Spolverato, Sebastiano Milite, Francesco Vendemiati
article en

Abstract

Abstract Purpose To evaluate the diagnostic accuracy of total-body 18 F-FDG PET/MRI compared with contrast-enhanced CT in detecting distant metastases in patients with locally advanced rectal cancer (LARC) after neoadjuvant chemoradiotherapy (pCRT). Methods This retrospective study included patients with LARC treated with pCRT between 2016 and 2019. Both contrast-enhanced CT and 18 F-FDG PET/MRI were performed within 6–8 weeks after completion of pCRT. Two independent expert teams assessed the presence of hepatic, pulmonary, lymph node, and other distant metastases. Histopathology and/or radiological follow-up served as the reference standard. Sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), and AUC were compared between the two modalities. Results Metastases were confirmed in 17/51 patients (33.3%). PET/MRI showed significantly higher specificity (100% vs. 86%, p = 0.0313), PPV (100% vs. 45.5%, p = 0.0313), and accuracy (96.1% vs. 82.4%, p = 0.0156) for the detection of liver metastases compared with CT. No significant differences were found for other metastatic sites; however, PET/MRI demonstrated overall better performance for global M staging (84.3% vs. 80.4%) and for detecting metastases outside the liver, lungs, or distant lymph nodes (100% vs. 94.1%). Conversely, CT showed higher accuracy than PET/MRI for the detection of pulmonary metastases (88.2% vs. 84.3%) and distant lymph node metastases (96.1% vs. 90.2%). Conclusions 18 F-FDG PET/MRI performs significantly better than CT in detecting liver metastases and demonstrates higher accuracy for overall M staging and for identifying metastases outside the liver, lungs, or distant lymph nodes after pCRT in patients with LARC. Although CT appears more accurate for detecting lung and distant lymph node metastases, PET/MRI may improve overall restaging accuracy.

Clinical and Translational Imaging
University of Padua (IT)
Università degli Studi di Padova
Good health and well-being
Openalex Percentile: Top 14%
Colorectal Cancer Surgical Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.